BRPI0923574A2 - processo para a preparação de uma forma em pó de peptídeo - Google Patents

processo para a preparação de uma forma em pó de peptídeo

Info

Publication number
BRPI0923574A2
BRPI0923574A2 BRPI0923574A BRPI0923574A BRPI0923574A2 BR PI0923574 A2 BRPI0923574 A2 BR PI0923574A2 BR PI0923574 A BRPI0923574 A BR PI0923574A BR PI0923574 A BRPI0923574 A BR PI0923574A BR PI0923574 A2 BRPI0923574 A2 BR PI0923574A2
Authority
BR
Brazil
Prior art keywords
preparing
powder form
peptide powder
peptide
powder
Prior art date
Application number
BRPI0923574A
Other languages
English (en)
Inventor
Hell André
Walch Christian
Strub Daniel
Vix Francis
Jansen Michael
Rothe Michael
Steidle Peter
Specker Remy
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0923574A2 publication Critical patent/BRPI0923574A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0923574A 2008-12-23 2009-12-15 processo para a preparação de uma forma em pó de peptídeo BRPI0923574A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08172689 2008-12-23
PCT/EP2009/067188 WO2010072621A2 (en) 2008-12-23 2009-12-15 Process for the preparation of a peptide powder form

Publications (1)

Publication Number Publication Date
BRPI0923574A2 true BRPI0923574A2 (pt) 2018-01-16

Family

ID=41560987

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923574A BRPI0923574A2 (pt) 2008-12-23 2009-12-15 processo para a preparação de uma forma em pó de peptídeo

Country Status (12)

Country Link
US (1) US20100183876A1 (pt)
EP (1) EP2381928A2 (pt)
JP (1) JP2012513438A (pt)
KR (1) KR20110086866A (pt)
CN (1) CN102256598B (pt)
AU (1) AU2009331683A1 (pt)
BR (1) BRPI0923574A2 (pt)
CA (1) CA2745557A1 (pt)
IL (1) IL213416A0 (pt)
MX (1) MX2011006429A (pt)
SG (1) SG172381A1 (pt)
WO (1) WO2010072621A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
WO2014077801A1 (en) * 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
CA2965759C (en) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
ES2674808B1 (es) * 2016-12-30 2019-04-11 Bioinicia S L Instalacion y procedimiento de encapsulado industrial de sustanciastermolabiles
MA54510A (fr) 2018-12-21 2022-03-30 Novo Nordisk As Procédé de séchage par pulvérisation de peptide glp-1
JP7601795B2 (ja) * 2019-02-06 2024-12-17 バイオコン・リミテッド Ｇｌｐ－１類似体の精製
CN113631251B (zh) * 2019-03-15 2025-04-25 诺和诺德股份有限公司 Glp-1肽的喷雾干燥工艺
AU2020299270A1 (en) * 2019-07-02 2021-12-23 F. Hoffmann-La Roche Ag Process for the preparation of high water affinity type products with controlled humidity
EP4025192B1 (en) * 2019-09-02 2025-12-03 Novo Nordisk A/S Process for producing a tablet comprising glp-1 peptides
CN116785738A (zh) * 2023-05-10 2023-09-22 广东日和堂医药科技有限公司 一种含五谷虫胶原蛋白肽粉末干燥方法
CN118465154B (zh) * 2024-07-12 2024-10-22 军科正源（北京）药物研究有限责任公司 一种用于检测贝那鲁肽的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1107743E (pt) * 1998-08-25 2007-10-01 Advanced Inhalation Res Inc Formulações proteicas estáveis secas por pulverização
CN1495198A (zh) * 1998-12-07 2004-05-12 �о���Ӧ�ÿ�ѧЭ��ɷ����޹�˾ 胰高血糖素样肽-1的类似物
US7919109B2 (en) * 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
WO2001093837A2 (en) * 2000-06-08 2001-12-13 Eli Lilly And Company Protein powder for pulmonary delivery
US20030125236A1 (en) * 2000-12-29 2003-07-03 Advenced Inhalation Research, Inc. Particles for inhalation having rapid release properties
AU2002308706A1 (en) * 2001-06-01 2002-12-16 Eli Lilly And Company Glp-1 formulations with protracted time action
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US7534763B2 (en) * 2004-07-02 2009-05-19 Bristol-Myers Squibb Company Sustained release GLP-1 receptor modulators
DK1888031T3 (da) * 2005-06-06 2013-02-18 Camurus Ab GLP-1-analogformuleringer
NZ573093A (en) * 2006-06-23 2012-01-12 Hoffmann La Roche Insulinotropic peptide synthesis
KR100805208B1 (ko) * 2007-03-27 2008-02-21 주식회사 펩트론 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법
ES2402172T3 (es) * 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
ES2563038T3 (es) * 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca

Also Published As

Publication number Publication date
CN102256598A (zh) 2011-11-23
AU2009331683A1 (en) 2010-07-01
WO2010072621A2 (en) 2010-07-01
CA2745557A1 (en) 2010-07-01
IL213416A0 (en) 2011-07-31
JP2012513438A (ja) 2012-06-14
CN102256598B (zh) 2017-12-22
MX2011006429A (es) 2011-07-20
KR20110086866A (ko) 2011-08-01
SG172381A1 (en) 2011-07-28
US20100183876A1 (en) 2010-07-22
WO2010072621A3 (en) 2011-01-06
EP2381928A2 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
BRPI0923574A2 (pt) processo para a preparação de uma forma em pó de peptídeo
BRPI0916712A2 (pt) processo para preparar uma composição detergente
BRPI0910033A2 (pt) processo para a modificação de superfícies de partículas
BR112013012108A2 (pt) processo para a preparação de um poliéster
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0908323A2 (pt) método para poduzir um artigo sobremoldado
BRPI1011743A2 (pt) processo para preparar poliéster insaturado
BRPI0910454A2 (pt) processo para produção de uma proteína policlonal
BRPI0813284A2 (pt) Processos para a preparação de pirazóis
BRPI0914674A2 (pt) processo para preparação de um pó
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
BRPI1012018A2 (pt) processo para preparar um composto
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI1014267A2 (pt) processo para a carbonitrificação
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BR112013005075A2 (pt) processo para produção de uma composição de ligante de cimento
BRPI0813858A2 (pt) Método para produzir peptídeo
BRPI0925100A2 (pt) forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BRPI0916512A2 (pt) processo para produzir uma composição agroquímica de partícula dispersível em água
BRPI0912558A2 (pt) Processo para a preparação de amidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]